Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03634982
Title Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Revolution Medicines, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Research Institute Scottsdale Arizona 85258 United States Details
City of Hope Duarte California 91010 United States Details
UC Irvine - Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
UC Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Sarah Cannon Research Institute - Florida Cancer Specialists Sarasota Florida 34232 United States Details
Moffit Cancer Center Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Oklahoma - Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute - Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
University of Texas at Austin - Dell Medical School Austin Texas 78712 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field